Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For patients with refractory acute respiratory distress syndrome (ARDS) due to COVID-19 infections, ...
Last October, the Wall Street Journal published a fascinating article that delved into the ethical considerations for hospitals due to the ever-improving outcomes being seen with Extracorporeal ...
A recent study published in the European Journal of Cardio-Thoracic Surgery found about 2% of patients undergoing congenital ...
Registry data reaffirmed extracorporeal membrane oxygenation (ECMO) as a reasonable strategy for COVID-19 patients with severe respiratory problems, with most survivors discharged home and several ...
Please provide your email address to receive an email when new articles are posted on . Mortality on extracorporeal membrane oxygenation was higher in the second wave of patients with COVID-19, ...
Background: Extracorporeal membrane oxygenation (ECMO) has emerged as an advanced therapeutic option for managing acute respiratory distress syndrome (ARDS), especially severe cases of ARDS. However, ...
In patients with rapidly deteriorating or severe cardiogenic shock, immediate use of extracorporeal membrane oxygenation (ECMO) does not improve outcomes over an initially conservative strategy with ...
BRENTWOOD, Tenn.--(BUSINESS WIRE)--SpecialtyCare— the nation’s leading provider of perfusion, ECMO, intraoperative neuromonitoring (IONM), and surgical services—announced today it has collaborated ...
Routine early, expeditious use of extracorporeal membrane oxygenation (ECMO) is a common strategy in patients with severe cardiogenic shock, but a less aggressive initial approach may be just as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results